Showing results (701-710 of 826) with videos related to

Sort By:
Pageof 83
Blood Transfusion = Trasfusione Del Sangue|March 12, 2015
A good manufacturing practice method to ex vivo expand natural killer cells for clinical useGiovanni F Torelli, Carmela Rozera, Laura Santodonato, et al.
Blood|April 4, 2002
Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell diseaseCharles H Pegelow, Eric A Macklin, Franklin G Moser, et al.
British Journal of Haematology|June 1, 2023
Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohortCarla Minoia, Lucia Diella, Tommasina Perrone, et al.
Leukemia & Lymphoma|July 22, 2016
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II studySamantha Pozzi, Massimo Gentile, Stefano Sacchi, et al.
British Journal of Haematology|February 10, 2011
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usageMichele Dal-Bo, Ilaria Del Giudice, Riccardo Bomben, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient ModelMassimo Martino, Sabino Ciavarella, Simona De Summa, et al.
Pharmacological Research|August 12, 2009
High mobility group box-1 expression correlates with poor outcome in lung injury patientsAlessandra Bitto, Mario Barone, Antonio David, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 16, 2021
Psychological well-being in cancer outpatients during COVID-19Daniela Bafunno, Francesca Romito, Fulvia Lagattolla, et al.
Hematological Oncology|October 31, 2012
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective studyPier Luigi Zinzani, Cinzia Pellegrini, Emanuela Merla, et al.
Scientific Reports|December 3, 2025
AI-derived five-gene signature predicts risk in multiple myeloma under bortezomib-based therapyGrazia Gargano, Susanna Anita Pappagallo, Angela Maria Quinto, et al.
Pageof 83